INTRODUCTION
The term solid dispersion refers to a group of solid products consisting of at least two different components, generally a hydrophilic matrix and a hydrophobic drug. The matrix can be either crystalline or amorphous. The drug can be dispersed molecularly, in amorphous particles (clusters) or in crystalline particles 1 .
Enhancement of bioavailability of poorly soluble drug has become draustic need and challenging aspects for the drug development phase
.
For the better absorption of the drug it is quite necessary that drug must be soluble and permeable which decides the bioavailability of the drug. So the formulation of poorly soluble drug for the drug delivery has becoming challenging to the research and development sectors and work is going through on this.
So in this case the major approach is the formulation approach which is quite simple and increases the solubility of the poorly soluble drug by the solid dispersion technique. This method, which was later, termed solid dispersion which involved the formation of eutectic mixture of drugs with water-soluble carriers by the melting of their physical mixtures.
On the basis generation solid dispersion broadly classified into 3 - 
First generation solid dispersions-

MATERIALS
Paracetamol (PCM) was gifted by Simpex Laboratories Kotdwar, India. PEG 4000, buffers was purchased from CDH, and all other chemicals used were of analytical grade.
METHODS
Preparation of physical mixture
The physical mixture of PCM and PEG 4000 was accurately taken in a mortar and triturated smoothly with the help of pestle so that mixing makes uniformly, drug and carrier mix with each other and distributed equally in both the phases. The resulting mixture formed was passed through the sieve no.80. The mixture was placed in a desiccator to carry the further characterization of prepared mixture.
Preparation of solid dispersion of PCM containing PEG 4000 as a carrier
Firstly the carrier PEG 4000 was melted in a china dish over a water bath at temperature 55 0 C, then the accurately amount of a PCM was incorporated in a molten carrier and with the help of glass rod, solid solution formed was properly mixed so that uniform mixing takes place. After that transfer the china dish over an ice bath and solidify the molten mixture, put this system into a desiccator fitted with vaccum remove the moisture from it, passed with the sieve and when use transfer in a capsule and evaluation was performed. 
Characterization of PCM solid dispersions
Saturation solubility studies of prepared solid dispersions
The excess amount of solid dispersions (physical mixtures and prepared dispersion) was added to the 10 ml volumetric flask which contains distilled water and subjected to kept for maintaining 37 0 C for 26 hours. Then the flask were removed and suitable amount of aliquots was taken and filtered by using whattmann filter paper and diluted by using distilled water and it is compare with the pure drug for solubility profile comparison.
Appearance of Paracetamol solid dispersion
By the help of projection microscope at magnification 10 x and 40 x the prepared PCM dispersion were analyzed to study the phase transformation between the states.
Drug content analysis
Preparation equivalent to 100 mg was accurately weighed and transferred to 100 ml volumetric flask and mixed in 100 ml phosphate buffer having pH 5.8., suitable aliquots were withdrawn and diluted to appropriate dilution and drug content was established using calibration curve of PCM at  max 243 nm. The drug content was estimated.
In -vitro release profile characteristics
In-vitro release of PCM from the solid solution were evaluated with a USP XXXI dissolution apparatus type II (paddle type, Electrolab, Mumbai, India) at 50 rpm in 900ml phosphate buffer (pH 5.8) at 37±0.5 0 C. At predetermined intervals, a 1ml aliquot was withdrawn and replenished with an equal volume of fresh dissolution medium. The withdrawn samples were analyzed spectrophotometrically at 243nm PCM solid dispersion formulations.
Kinetics of drug release
The results of in vitro release profiles obtained for all the formulations were fitted into four models of data treatment as follows:
1. Cumulative percent drug released versus time (zeroorder kinetic model).
2. Log cumulative percent drug remaining versus time (first-order kinetic model).
3. Cumulative percent drug released versus square root of time (Higuchi's model).
4. Log cumulative percent drug released versus log time (Korsemeyer-Peppas equation).
Stability studies
The stability studies of selected formulation was carried out at the room temperature in a hermitically sealed ampoules for 6 months to observe any change in physical characteristics, drug content and whether any drug release profile alters or not while storage.
RESULTS AND DISCUSSION
Callibration curve of Paracetamol in 5.8 pH phosphate buffer The solubility profile of solid dispersion, physical mixture and pure drug was found to be and depicted in the following table 2. Paracetamol is purely water insoluble drug and its solubility at room temperature in pure distilled water was estimated 0.079 mg/ml. But the dispersion of PCM with PEG 4000 proves a better solubility profile and increases the solubility of PCM with as the carrier proportion increases. In formulation F1* there is marked increase of solubility of PCM with physical mixture of PEG 4000 by trituration method, because there is less intimate between the drug and carrier so this not so affect the solubility of PCM in physical mixture (F1*).
In the another formulations (F1 to F4), the dispersion prepared by the melting solidification technique so in this there is may be inherent transitions takes place between the drug and carrier in manner of hydration, increase in wettability phenomenon and possible complex formation with the carriers which leads to increase in the solubility ranging from 0.204mg/ml to 0.253 mg/ml.
Appearance of Paracetamol solid dispersion
Pure form of PCM having the crystalline nature where as the physical mixture of PEG:PCM having the off sticky appearance and the prepared solid dispersion of formulation shows the solid sticky lumps at temperature 37 o C but at above this temperature it starts melting and physical property on the basis of integrity of dispersions it starts changing as the temperature and time progress. Preparation equivalent to 100 mg was accurately weighed and transferred to 100 ml volumetric flask and mixed in 100 ml phosphate buffer having pH 5.8., suitable aliquots were withdrawn and diluted to appropriate dilution and drug content was established using calibration curve of PCM at  max 243 nm. The drug content was found to be between 93.78% to 99.04% as compared with respect to the standard one. This explains that the drug is properly dispersed in the carrier phase which shows the higher significance value.
In vitro release profile study
The formulation of solid dispersions with carrier like PEG 4000 was formulated and proves a better release profile at pH 5.8 phosphate buffer. However it was also experimented and observed that the prepared solid dispersions with these carriers shows a better release characteristics as compared with the raw drug (RD) and physical mixture (F1*). Formulation F4 reveals the faster dissolution rate as compared to the other formulations because in this the ratio of carrier is high and this leads to the faster release of this formulation. From the release graph which was plotted against the time also shows there is slowly release of the drug from this carrier because at the earlier of the few minutes there is not enough time to get between the carrier and media to increase the wettability of the carriers and as the time progresses the wetability increases and this finally leads to the better release of the drug.
These observations however indicates that the better and enhanced dissolution of the dispersions is due to the increased wettability of the drug and carrier, particle size reduction in the case of during preparation and phase transformation between these two. 
Release kinetics of the solid dispersions
The in vitro release kinetics of various formulations was analyzed by fitting the various models as mentioned in the above table. While establishing the release kinetics with various formulations it was found that the formulation RD, F1*, F1, F2 and F4 fallows a zero order kinetics because in this calculated r 2 value were higher and it explains that the release rate is independent of the concentration of the drug. While establishing connection to the release kinetics in F3 it was observed that the r 2 value in Higuchi role model was higher and it reveals that the solid drug is dispersed in a soluble matrix and the rate of drug release is related to the rate of drug diffusion. The n values from drug release experiment ranged from 0.58-0.78, indicated anomalous non-Fickian transport, which suggest that mechanism and kinetics of drug release were dependent on the solubility of solid dispersion formulation in dissolution medium. 
Stability studies of the solid dispersions
In the present contrast of study we have done some extent of stability study as per the established guidelines. During this the prepared dispersions were sealed in hermitically sealed containers (ampoules) of different formulations. After storage at room conditions for six months the prepared solid dispersions were characterized for physical appearance, solubility studies, drug content analysis and dissolution profile studies.
It was found that there is no any much more changes occur to the solid dispersions formulations with using PEG 4000 as a carrier. However there is much more study needed during the stability studies of dispersion by following the ICH guidelines.
CONCLUSION
In this present study we have prepared the solid dispersion of Paracetamol using PEG 4000 as a carrier. Due to hydrophilic nature of this carrier molecule this supports the creation of hydrophilic environment to the dispersion solid and increases the wettability of the Paracetamol which leads to increase in the dissolution rate. In this study we observe that by increasing the concentration of carrier the dissolution and solubility profile also increases. This carrier also proves the better in terms of stability. We propose that the prepared solid dispersion using PEG 4000 was able to improve the solubility and dissolution profile of poorly water soluble drug without changing in its integrity.
